Badr G, Sayed D
Zoology Department, Faculty of Science, Assiut University, Assiut, Egypt.
Egypt J Immunol. 2006;13(2):23-31.
Cytokines play important roles in the growth and growth arrest of cancer cells. IL-13 via an IL-4R alpha/IL-13R alpha 1 heterocomplex receptor inhibits the growth of renal cell carcinoma cells (RCC). However, it does not inhibit the growth of glioblastoma cells that express the IL-13R alpha 2 chain. In the present studies we investigated whether melanoma cells express IL-13R alpha 1 and IL-13R alpha 2 chains as well as whether they respond to IL-13. Membrane IL13R alpha 2 was co-expressed with IL-4R alpha and IL-13R alpha 1 chains in three of six tested melanoma cell lines. Furthermore, the IL-13R alpha 2 positive cell lines, release a soluble form of IL-13R alpha 2, specifically under IL-13 but not IL-4 stimulation. The release of soluble IL-13R alpha 2 was inhibited by various metalloproteinase inhibitors and EDTA inhibits the biological response to IL-13.
细胞因子在癌细胞的生长和生长停滞中发挥重要作用。白细胞介素-13(IL-13)通过白细胞介素-4受体α(IL-4Rα)/白细胞介素-13受体α1(IL-13Rα1)异源复合受体抑制肾癌细胞(RCC)的生长。然而,它并不抑制表达白细胞介素-13受体α2链的胶质母细胞瘤细胞的生长。在本研究中,我们调查了黑色素瘤细胞是否表达白细胞介素-13受体α1和白细胞介素-13受体α2链,以及它们是否对白细胞介素-13有反应。在六个测试的黑色素瘤细胞系中的三个中,膜白细胞介素-13受体α2与白细胞介素-4受体α和白细胞介素-13受体α1链共表达。此外,白细胞介素-13受体α2阳性细胞系,特别是在白细胞介素-13而非白细胞介素-4刺激下,释放可溶性形式的白细胞介素-13受体α2。可溶性白细胞介素-13受体α2的释放受到各种金属蛋白酶抑制剂的抑制,而乙二胺四乙酸(EDTA)抑制对白细胞介素-13的生物学反应。